FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely to a stable pharmaceutical composition of nanostructured telmisartan for treating hypertension, containing nanostructured telmisartan having an average particle size less than approximately 600 nm, and at least one stabilising agent specified in a group of sodium dodecyl sulphate and polyvinyl pyrrolidone, wherein the composition in prepared in a continuous flow reactor, preferentially in a microfluidics continuous flow reactor, as well as to a method for preparing the composition and using it.
EFFECT: invention provides better physical-chemical characteristics and pharmacokinetics of the active principle.
11 cl, 9 ex, 3 tbl, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NANOSTRUCTURED SILDENAFIL BASE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND COCRYSTALS, THEIR COMPOSITIONS METHOD OF PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2010 |
|
RU2545784C2 |
| COMPOSITION OF NANOSTRUCTURED APREPITANT, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2011 |
|
RU2595841C2 |
| OXICODON AND NALOXON-CONTAINING PHARMACEUTICAL COMPOSITIONS WITH INSTANT RELEASE | 2010 |
|
RU2522212C2 |
| HYDROCODON PREPARATIVE SUSTAINED-RELEASE FORMULATIONS | 2000 |
|
RU2230556C2 |
| PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
| PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
| SOLID COMPOSITIONS BASED ON BETAHISTINE FOR ORAL ADMINISTRATION WITH NON-PULSATING PROLONGED RELEASE | 2018 |
|
RU2774644C2 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
| SOLID DOSAGE FORMS OF ONDANSETRON WITH PROLONGED RELEASE FOR TREATING SYMPTOMS OF NAUSEA, VOMITING AND DIARRHEA | 2015 |
|
RU2706708C2 |
